Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT TrialEur Urol 2021 Jan 15;[EPub Ahead of Print], RJ Motzer, P Russo, N Haas, C Doehn, F Donskov, M Gross-Goupil, S Varlamov, E Kopyltsov, JL Lee, HY Lim, B Melichar, M Zemanova, B Rini, TK Choueiri, L Wood, MN Reaume, A Stenzl, S Chowdhury, R McDermott, A Michael, M Izquierdo, P Aimone, H Zhang, CN Sternberg
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.